Pseudoplatelets: a retrospective study of their incidence and interference with platelet counting
- 1Department of Clinical Chemistry, University Medical Centre St Radboud, 6500 HB Nijmegen, The Netherlands
- 2Department of Haematology, University Medical Centre St Radboud
- Correspondence to: Dr W van der Meer, Department of Clinical Chemistry (564), University Medical Centre St Radboud, PO BOX 9101, 6500 HB Nijmegen, The Netherlands; w.vandermeer{at}akc.umcn.nl
- Accepted 15 April 2003
Abstract
Aims: Spurious platelet counts can be found in acute leukaemias, as a result of the fragmentation of blood cells. Microscopic examination of a blood smear should be performed to detect the presence of these so called pseudoplatelets. When present, the platelet count should be corrected because of the important clinical consequences that a lower platelet count may have in these patients.
Methods: K3EDTA anticoagulated blood was measured on an automated blood cell counter, and a blood smear was made and stained according the May Grünwald–Giemsa method for microscopic observation. A 500 cell/particle differentiation was performed and the automated platelet count was corrected.
Results: The incidence of pseudoplatelets in 169 patients with acute leukaemia was studied. Pseudoplatelets were detected in 43 patients (25.4%), and seven patients (4.1%) were re-classified as having a major bleeding risk (platelet count, < 15 × 109/litre).
Conclusions: Platelets should be determined morphologically in patients with acute leukaemia and a routine screening method for the detection of pseudoplatelets should be developed.
- ALL, acute lymphoblastic leukaemia
- AML, acute myeloid leukaemia
- CBC, complete blood cell count
- DIC, disseminated intravascular coagulation








